86 related articles for article (PubMed ID: 17907514)
1. The role of splenectomy in children with juvenile myelomonocytic leukemia.
Ozyürek E; Cetin M; Tuncer M; Hiçsönmez G
Turk J Pediatr; 2007; 49(2):154-7. PubMed ID: 17907514
[TBL] [Abstract][Full Text] [Related]
2. Treatment of pediatric myelodysplastic syndromes and juvenile myelomonocytic leukemia: the Brazilian experience in the past decade.
Valera ET; Latorre Mdo R; Mendes WL; Seber A; Lee ML; de Paula MJ; Loggetto SR; Velloso E; Niero-Melo L; Lopes LF;
Leuk Res; 2004 Sep; 28(9):933-9. PubMed ID: 15234570
[TBL] [Abstract][Full Text] [Related]
3. [What to improve in approach to diagnose and treat pediatric myelodysplastic syndromes and juvenile myelomonocytic leukemia in Poland?].
Wójcik D; Pietras W; Ussowicz M; Chybicka A
Przegl Lek; 2006; 63(1):29-30. PubMed ID: 16892896
[TBL] [Abstract][Full Text] [Related]
4. Splenectomy reduces packed red cell transfusion requirement in children with sickle cell disease.
Haricharan RN; Roberts JM; Morgan TL; Aprahamian CJ; Hardin WD; Hilliard LM; Georgeson KE; Barnhart DC
J Pediatr Surg; 2008 Jun; 43(6):1052-6. PubMed ID: 18558181
[TBL] [Abstract][Full Text] [Related]
5. Partial splenectomy for children with congenital hemolytic anemia and massive splenomegaly.
Diesen DL; Zimmerman SA; Thornburg CD; Ware RE; Skinner M; Oldham KT; Rice HE
J Pediatr Surg; 2008 Mar; 43(3):466-72. PubMed ID: 18358283
[TBL] [Abstract][Full Text] [Related]
6. Splenectomy after angiographic embolization of the splenic artery in patients with massive splenomegaly and severe thrombocytopenia, in juvenile subacute myelomonocytic leukemia.
Steinherz PG; Exelby PR; Young J; Watson RC
Med Pediatr Oncol; 1984; 12(1):28-32. PubMed ID: 6583468
[TBL] [Abstract][Full Text] [Related]
7. Outcome of splenectomy in children younger than 4 years with sickle cell disease.
Lesher AP; Kalpatthi R; Glenn JB; Jackson SM; Hebra A
J Pediatr Surg; 2009 Jun; 44(6):1134-8; discussion 1138. PubMed ID: 19524729
[TBL] [Abstract][Full Text] [Related]
8. Laboratory markers of thrombosis risk in children with hereditary spherocytosis.
Troendle SB; Adix L; Crary SE; Buchanan GR
Pediatr Blood Cancer; 2007 Nov; 49(6):781-5. PubMed ID: 17854065
[TBL] [Abstract][Full Text] [Related]
9. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options.
Niemeyer CM; Kratz CP
Br J Haematol; 2008 Mar; 140(6):610-24. PubMed ID: 18302710
[TBL] [Abstract][Full Text] [Related]
10. Acute chest syndrome after splenectomy in children with sickle cell disease.
Ghantous S; Al Mulhim S; Al Faris N; Abushullaih B; Shalak F; Yazbeck S
J Pediatr Surg; 2008 May; 43(5):861-4. PubMed ID: 18485954
[TBL] [Abstract][Full Text] [Related]
11. [Unrelated umbilical cord blood transplantation as a treatment for children with malignant leukemia].
Tang XF; Luan Z; Xu SX; Wu NH; Huang YZ; Wang K
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):5-8. PubMed ID: 18289460
[TBL] [Abstract][Full Text] [Related]
12. Acute splenic complications and implications of splenectomy in hemoglobin SC disease.
Subbannan K; Ustun C; Natarajan K; Clair B; Daitch L; Fields S; Kutlar F; Kutlar A
Eur J Haematol; 2009 Sep; 83(3):258-60. PubMed ID: 19459924
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
14. Splenectomy in two children with autoimmune lymphoproliferative syndrome and massive splenomegaly.
Glerup M; Thelle T; Grønbaek K; Hasle H
Pediatr Blood Cancer; 2009 Dec; 53(6):1124-6. PubMed ID: 19499578
[TBL] [Abstract][Full Text] [Related]
15. [Prophylactic splenectomy to prevent complications of splenomegaly in children with sickle cell anemia?].
Gnassingbe K; Akakpo-Numado GK; Attipou K; Gbadoe A; Tekou H
Sante; 2007; 17(4):207-11. PubMed ID: 18299263
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.
Vancine-Califani SM; De Paula EV; Ozelo MC; Orsi FL; Fabri DR; Annichino-Bizzacchi JM
Platelets; 2008 Nov; 19(7):489-95. PubMed ID: 18979360
[TBL] [Abstract][Full Text] [Related]
17. A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia.
Yabe M; Sako M; Yabe H; Osugi Y; Kurosawa H; Nara T; Tokuyama M; Adachi S; Kobayashi C; Yanagimachi M; Ohtsuka Y; Nakazawa Y; Ogawa C; Manabe A; Kojima S; Nakahata T;
Pediatr Transplant; 2008 Dec; 12(8):862-7. PubMed ID: 18397212
[TBL] [Abstract][Full Text] [Related]
18. Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.
Abdelhameed A; Pond GR; Mitsakakis N; Brandwein J; Chun K; Gupta V; Kamel-Reid S; Lipton JH; Minden MD; Schimmer A; Schuh A; Yee K; Messner HA
Cancer; 2008 Apr; 112(7):1513-21. PubMed ID: 18286528
[TBL] [Abstract][Full Text] [Related]
19. Indication for splenectomy in the era of living-donor liver transplantation.
Jeng LB; Lee CC; Chiang HC; Chen TH; Hsu CH; Cheng HT; Lai HC
Transplant Proc; 2008 Oct; 40(8):2531-3. PubMed ID: 18929791
[TBL] [Abstract][Full Text] [Related]
20. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
